Management

Daniel is a seasoned executive with over 25 years of experience in executive leadership roles in high-tech and medical device companies (Nasdaq traded and start-ups). He served as Chief Commercial Officer and CEO/GM at Datum Dental, and was part of leading the company to a successful exit. Prior to this, he contributed to Syneron Candela, a leading Aesthetic Laser company. Daniel holds a B.Sc. in Industrial & Management Engineering from Ben-Gurion University, Israel, and an Executive MBA from the Hebrew University. His expertise lie in strategic leadership, global commercial execution, as well as driving innovation and organizational growth in the biotech sector.

Dr. Yotam Levin has been the CEO of NanoPass Technologies Ltd. since 2002.  He is in charge of the Company's innovation and R&D strategy, and all clinical activities. Under his supervision the company successfully licensed its product with the FDA and the European authorities, and conducted pioneering intradermal vaccination studies. Prior to becoming CEO at NanoPass, Dr Levin was head of the biomedical consulting practice at Global Business Solutions, an Israeli strategic consulting firm. Dr Levin holds an MD degree and an MBA (finance), both from Tel Aviv University, Israel. Dr Levin authored several key publications in leading journals such as the Lancet Infectious Diseases, Vaccine, Journal of Infectious diseases (JID) and Human Vaccines & Immunotherapeutics (HV&I(, and participated in authoring over a two-dozen patent applications. He serves as a frequent reviewer for Vaccine, JID and HV&I, and was a Guest Editor for Vaccine’s Skin Vaccination Summit 2015. In his spare time, he runs marathons, teaches biomedical entrepreneurship and volunteers with a disabled children NPO.

Dr. Efrat Kochba joined NanoPass Technologies Ltd. in 2012 as medical director and is in charge of managing the clinical activities of the company, Serving as the subject matter expert supporting our key-opinion-leader/clinicians community, providing clinical training and support for our business partners globally and medical inputs to our innovation roadmap.  Dr. Kochba brings a wide experience in the field of drug delivery working for TransPharma Medical Ltd., a company that focused on transdermal drug delivery. Efrat holds an MD degree from the Hebrew university in Jerusalem and practiced ENT medicine for six years prior to joining Roche pharmaceuticals as a medical and clinical trials manager.

Tal is a seasoned executive with 20 years of commercial experience in the high-tech and medical device sectors. He has held leadership roles in both Nasdaq-listed companies and start-ups. Prior to joining Nanopass, Tal served as the Marketing and Commercial Director for the Regenerative Business Unit at Dentsply Sirona (XRAY). He has also held key business roles at global technology companies, including Bluedot, Stratasys (SSYS), Ceragon Networks (CRNT), and NICE Systems (NICE). Tal earned a Bachelor's degree in Industrial and Management Engineering from Shenkar College, Israel, and an Executive MBA from Bar-Ilan University.

Yoav brings over 15 years of expertise in mechanical engineering, engineering management, and the medical devices and printing industries, with a specialized focus on non-invasive fat reduction technologies. He has extensive experience in product development within ISO 13485 environments, as well as designing and managing multidisciplinary, large-scale machines. Yoav has successfully led global engineering teams and operational systems, overseeing the establishment of manufacturing processes, product lines, and scaling operations to mass production. Yoav holds a B.Sc. in Mechanical Engineering from Ben-Gurion University.

Ayala, Quality Assurance and Regulatory Affairs (QA/RA) Director, joined NanoPass in 2022 and brings over 13 years of experience in the medical device industry. She holds a B.Sc. in Biology from Ben-Gurion University and an M.Sc. in Epidemiology from Tel Aviv University. With extensive knowledge in QA and RA, Ayala excels at devising creative solutions to regulatory challenges and aligning RA strategies with marketing objectives.QA/RA Director

Yafit Keret is a seasoned finance leader, CPA, and entrepreneur with over 20 years of experience driving financial strategy and operational excellence for technology companies and growth-stage organizations.

As Founder & CEO of Proximo, she combines deep expertise in finance, strategic planning, and business transformation to help companies navigate complex challenges and accelerate sustainable growth. Known for her commitment to aligning finance with long-term vision, Yafit has established herself as a trusted advisor and thought leader in leadership, finance, and innovation. She is also active in the broader startup and deep-tech community, contributing as a speaker, mentor, and judge for emerging talent and initiatives in AI and women’s entrepreneurship.